Medexus Pharmaceuticals Inc. (MEDXF)
| Previous Close | 2.1250 |
| Open | 2.1300 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 2.1300 - 2.1300 |
| 52 Week Range | 1.5400 - 6.7900 |
| Volume | |
| Avg. Volume | 4,590 |
| Market Cap | 41.907M |
| Beta (5Y Monthly) | 1.15 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Medexus Pharmaceuticals Announces Resubmission of Treosulfan NDA
Additional data collection and analysis reconfirms confidence in New Drug Application for TreosulfanNDA resubmission date consistent with previously announced timelineFDA decision still expected within six months of resubmission TORONTO and CHICAGO, April 22, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) and medac, a strategic partner of Medexus, are pleased to announce that medac has resubmitted its New Drug Application for Treosulfan (NDA) with the U.S. F
- GlobeNewswire
Medexus to Present at the Bloom Burton & Co. Healthcare Investor Conference
TORONTO and CHICAGO, April 19, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) will be presenting at the Bloom Burton & Co. Healthcare Investor Conference from May 2 to 3, 2022. The conference brings together U.S., Canadian, and international investors interested in the latest developments in the Canadian healthcare sector. Event: Bloom Burton & Co. Healthcare Investor ConferenceEvent Dates: May 2 to 3, 2022Medexus Presentation: May 2, 2022, at 11:30 am Toron
- GlobeNewswire
Medexus to Participate in the 34th Annual Roth Conference
TORONTO and CHICAGO, March 09, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that it will be participating in the 34th Annual Roth Conference from March 13 to 15, 2022. Event: 34th Annual Roth Conference Date: March 13-15, 2022 Location: Dana Point, CA This year’s event will consist of 1-on-1 / small group meetings, analyst-selected fireside chats, thematic industry panels, and on-demand presentations by execut
